Aromatase (CYP19) Polymorphism Between AI-responsive and AI-resistant Breast Cancer in Korea

NCT01137136 · clinicaltrials.gov ↗

SUSPENDED

Status

300

Enrollment

OTHER

Sponsor class

Stopped Because of economic issue, we could just enrolled total 150 patients.

Conditions

Polymorphism
CYP19
Aromatase Inhibitor

Sponsor

Samsung Medical Center